Is the direct sales model they keep talking about for software sales or training sales? My understanding was the bulk of the investment was in the software side of the business, yet 15% less revenue in FY22. Can someone remind me what the increased investment on staff has been. If it wasn't for the training side of the business propping them up this would be a disastrous annual report.
- Forums
- ASX - By Stock
- SCL
- Ann: Appendix 4E and Annual Report
Ann: Appendix 4E and Annual Report, page-2
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SCL (ASX) to my watchlist
(20min delay)
|
|||||
Last
18.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.472M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2750 | 10.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.5¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2750 | 0.105 |
1 | 5000 | 0.100 |
1 | 10000 | 0.050 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.165 | 10000 | 1 |
0.170 | 85778 | 3 |
0.175 | 30000 | 1 |
0.190 | 700 | 1 |
0.200 | 84267 | 3 |
Last trade - 16.12pm 12/06/2024 (20 minute delay) ? |
Featured News
SCL (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
SPONSORED BY The Market Online